Alice Gibbs

By Alice Gibbs

Senior Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


By 2050, drug-resistant "superbugs" could kill up to 10 million people a year, according to the World Health Organization. Antibiotics, the miracle drugs that revolutionized medicine in the 20th century, are rapidly losing their power.

But a forgotten treatment, first discovered more than a century ago, could offer hope. Known as bacteriophage therapy—or "phage therapy," for short—it uses viruses that naturally prey on bacteria, hijacking and destroying them from the inside out.

Once overshadowed by penicillin, phage research is now getting a second look as scientists race to find new ways to fight infections.

Read More on Health

Hospital IV drip

...

A new study published in Cell Reports has found that bacteria can pull off a dramatic survival trick when attacked by viruses.

Instead of letting the infection spread, the bacterium creates a kind of internal "quarantine zone" around the virus, cutting it off from the rest of the cell. Trapped without resources, the virus can't make copies of itself and will die out.

Scientists at the University of Melbourne and the Hebrew University of Jerusalem discovered this after used powerful imaging tools that can zoom into cells in 3D, alongside genetic experiments. These methods let them watch, almost in real time, how the bacteria wall off the invading virus.

"We found that bacteria attacked by phages can divide asymmetrically in a way that they can exclude the infected part and save the rest of the cell," paper author and microbiologist professor Sigal Ben-Yehuda told Newsweek.

Understanding how this deference mechanism works, the researchers explained, is an essential first step in working out how to neutralize it to make phage therapies more effective.

"This enables us to understand how bacteria can rescue themselves following phage attack, this is a previously unknown mechanism," Ben-Yehuda said. "As phage therapy is a growing field, such understanding could be important."

One approach, for example, might involve adding a special compound that would prevent the bacteria's sensor protein from detecting the phage.

Phage therapies can be used in medicine in various ways, depending on the nature of an infection. Approaches being studied or already in limited use include pills and liquids, topical creams, sprays or dressings and intravenous injections.

Last year, phage therapies helped save a pet cat named Squeaks from a multidrug-resistant infection after months of failed antibiotic treatment.

Veterinarians in Israel used a carefully tailored mix of phages applied directly to the wound on the cat's leg, alongside antibiotics that no longer worked on their own. Within weeks, the infection cleared and the surgical site healed—the first documented use of personalized phage therapy in animals.

Why it matters

Antibiotics have been a go-to for fighting bacteria for nearly a century, but bacteria are becoming increasingly resistant to antibiotics.

Use of antibiotics has risen by more than 21 percent since 2016, and a recent study by the Global Research on Antimicrobial Resistance (GRAM) Project published in The Lancet found that over 1 million people die each year from antimicrobial resistance, which includes resistance to antibiotics, antifungals, antiparasitics and antivirals.

Phage therapy is still considered experimental in much of the Western world, though it's been used for decades in countries like Georgia and Poland.

Breakthroughs like this new discovery give the field fresh momentum, offering hope that phages could one day join or even replace antibiotics in treating stubborn infections.

Do you have a tip on a health story that Newsweek should be covering? Do you have a question about phage therapy? Let us know via health@newsweek.com.

Update 09/12/25, 5:39 a.m. ET: This article was updated with additional information and comments from Professor Sigal Ben-Yehuda.

References

Fiyaksel, O. P., Dalvi, S. P., Zhou, B., Ravins, M., Shraiteh, B., Bhattacharya, S., Kirillov, S., Kaur, P., Rosenshine, I., Ghosal, D., & Ben-Yehuda, S. (2025). A bacterial host factor confines phage localization for excluding the infected compartment through cell division. Cell Reports, 44(7). https://doi.org/10.1016/j.celrep.2025.115994

Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Aguilar, G. R., Mestrovic, T., Smith, G., Han, C., Hsu, R. L., Chalek, J., Araki, D. T., Chung, E., Raggi, C., Hayoon, A. G., Weaver, N. D., Lindstedt, P. A., Smith, A. E., ... Murray, C. J. L. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1

‌

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines